Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
- PMID: 28919118
- PMCID: PMC5605707
- DOI: 10.1016/S0140-6736(17)32130-X
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Erratum in
-
Department of Error.Lancet. 2017 Oct 28;390(10106):e38. doi: 10.1016/S0140-6736(17)32648-X. Epub 2017 Oct 13. Lancet. 2017. PMID: 29032998 Free PMC article. No abstract available.
Abstract
Background: Measurement of changes in health across locations is useful to compare and contrast changing epidemiological patterns against health system performance and identify specific needs for resource allocation in research, policy development, and programme decision making. Using the Global Burden of Diseases, Injuries, and Risk Factors Study 2016, we drew from two widely used summary measures to monitor such changes in population health: disability-adjusted life-years (DALYs) and healthy life expectancy (HALE). We used these measures to track trends and benchmark progress compared with expected trends on the basis of the Socio-demographic Index (SDI).
Methods: We used results from the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 for all-cause mortality, cause-specific mortality, and non-fatal disease burden to derive HALE and DALYs by sex for 195 countries and territories from 1990 to 2016. We calculated DALYs by summing years of life lost and years of life lived with disability for each location, age group, sex, and year. We estimated HALE using age-specific death rates and years of life lived with disability per capita. We explored how DALYs and HALE differed from expected trends when compared with the SDI: the geometric mean of income per person, educational attainment in the population older than age 15 years, and total fertility rate.
Findings: The highest globally observed HALE at birth for both women and men was in Singapore, at 75·2 years (95% uncertainty interval 71·9-78·6) for females and 72·0 years (68·8-75·1) for males. The lowest for females was in the Central African Republic (45·6 years [42·0-49·5]) and for males was in Lesotho (41·5 years [39·0-44·0]). From 1990 to 2016, global HALE increased by an average of 6·24 years (5·97-6·48) for both sexes combined. Global HALE increased by 6·04 years (5·74-6·27) for males and 6·49 years (6·08-6·77) for females, whereas HALE at age 65 years increased by 1·78 years (1·61-1·93) for males and 1·96 years (1·69-2·13) for females. Total global DALYs remained largely unchanged from 1990 to 2016 (-2·3% [-5·9 to 0·9]), with decreases in communicable, maternal, neonatal, and nutritional (CMNN) disease DALYs offset by increased DALYs due to non-communicable diseases (NCDs). The exemplars, calculated as the five lowest ratios of observed to expected age-standardised DALY rates in 2016, were Nicaragua, Costa Rica, the Maldives, Peru, and Israel. The leading three causes of DALYs globally were ischaemic heart disease, cerebrovascular disease, and lower respiratory infections, comprising 16·1% of all DALYs. Total DALYs and age-standardised DALY rates due to most CMNN causes decreased from 1990 to 2016. Conversely, the total DALY burden rose for most NCDs; however, age-standardised DALY rates due to NCDs declined globally.
Interpretation: At a global level, DALYs and HALE continue to show improvements. At the same time, we observe that many populations are facing growing functional health loss. Rising SDI was associated with increases in cumulative years of life lived with disability and decreases in CMNN DALYs offset by increased NCD DALYs. Relative compression of morbidity highlights the importance of continued health interventions, which has changed in most locations in pace with the gross domestic product per person, education, and family planning. The analysis of DALYs and HALE and their relationship to SDI represents a robust framework with which to benchmark location-specific health performance. Country-specific drivers of disease burden, particularly for causes with higher-than-expected DALYs, should inform health policies, health system improvement initiatives, targeted prevention efforts, and development assistance for health, including financial and research investments for all countries, regardless of their level of sociodemographic development. The presence of countries that substantially outperform others suggests the need for increased scrutiny for proven examples of best practices, which can help to extend gains, whereas the presence of underperforming countries suggests the need for devotion of extra attention to health systems that need more robust support.
Funding: Bill & Melinda Gates Foundation.
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Figures
Similar articles
-
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.Lancet. 2016 Oct 8;388(10053):1603-1658. doi: 10.1016/S0140-6736(16)31460-X. Lancet. 2016. PMID: 27733283 Free PMC article.
-
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.Lancet. 2018 Nov 10;392(10159):1859-1922. doi: 10.1016/S0140-6736(18)32335-3. Lancet. 2018. PMID: 30415748 Free PMC article.
-
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.Lancet. 2015 Nov 28;386(10009):2145-91. doi: 10.1016/S0140-6736(15)61340-X. Epub 2015 Aug 28. Lancet. 2015. PMID: 26321261 Free PMC article.
-
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Lancet. 2015 Aug 22;386(9995):743-800. doi: 10.1016/S0140-6736(15)60692-4. Epub 2015 Jun 7. Lancet. 2015. PMID: 26063472 Free PMC article. Review.
-
Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.Lancet. 2018 Sep 22;392(10152):1015-1035. doi: 10.1016/S0140-6736(18)31310-2. Epub 2018 Aug 23. Lancet. 2018. PMID: 30146330 Free PMC article. Review.
Cited by
-
Prevalence of osteoarthritis in lower middle- and low-income countries: a systematic review and meta-analysis.Rheumatol Int. 2021 Jul;41(7):1221-1231. doi: 10.1007/s00296-021-04838-y. Epub 2021 Apr 27. Rheumatol Int. 2021. PMID: 33907879 Free PMC article.
-
Retrospective analysis of the relationship between bone mineral density and body composition in a health check-up Chinese population.Front Endocrinol (Lausanne). 2022 Aug 10;13:965758. doi: 10.3389/fendo.2022.965758. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36034420 Free PMC article.
-
Prevalence of Postural Changes and Musculoskeletal Disorders in Young Adults.Int J Environ Res Public Health. 2023 Dec 17;20(24):7191. doi: 10.3390/ijerph20247191. Int J Environ Res Public Health. 2023. PMID: 38131742 Free PMC article.
-
Individually or as a Team-The Immunological Milieu in the Lung Caused by Migrating Single-Sex or Mixed-Sex Larvae of Schistosoma mansoni.Pathogens. 2023 Dec 8;12(12):1432. doi: 10.3390/pathogens12121432. Pathogens. 2023. PMID: 38133315 Free PMC article.
-
Early life exposure to broccoli sprouts confers stronger protection against enterocolitis development in an immunological mouse model of inflammatory bowel disease.mSystems. 2023 Dec 21;8(6):e0068823. doi: 10.1128/msystems.00688-23. Epub 2023 Nov 9. mSystems. 2023. PMID: 37942948 Free PMC article.
References
-
- Mathers CD, Sadana R, Salomon JA, Murray CJ, Lopez AD. Healthy life expectancy in 191 countries, 1999. Lancet. 2001;357:1685–1691. - PubMed
-
- Murray CJ, Vos T, Lozano R. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197–2223. - PubMed
-
- Murray CJ, Salomon JA, Mathers CD, Lopez AD. Summary measures of population health. Concepts, ethics, measurement and applications. World Health Organization; Geneva: 2002.
MeSH terms
Grants and funding
- MR/K00669X/1/MRC_/Medical Research Council/United Kingdom
- P30 AG047845/AG/NIA NIH HHS/United States
- MC_UU_12011/2/MRC_/Medical Research Council/United Kingdom
- MC_UU_12011/1/MRC_/Medical Research Council/United Kingdom
- MC_UP_A620_1014/MRC_/Medical Research Council/United Kingdom
- R01 HD084233/HD/NICHD NIH HHS/United States
- R01 HD087993/HD/NICHD NIH HHS/United States
- U54 HG007479/HG/NHGRI NIH HHS/United States
- MC_U147585827/MRC_/Medical Research Council/United Kingdom
- WT_/Wellcome Trust/United Kingdom
- MC_UU_12017/15/MRC_/Medical Research Council/United Kingdom
- MR/K013351/1/MRC_/Medical Research Council/United Kingdom
- MC_UP_A620_1015/MRC_/Medical Research Council/United Kingdom
- CDF-2011-04-048/DH_/Department of Health/United Kingdom
- 201900/Z/16/Z/WT_/Wellcome Trust/United Kingdom
- P01 HD031921/HD/NICHD NIH HHS/United States
- R01 MH110163/MH/NIMH NIH HHS/United States
- R01 AI043596/AI/NIAID NIH HHS/United States
- SCAF/15/02/CSO_/Chief Scientist Office/United Kingdom
- U01 AI096299/AI/NIAID NIH HHS/United States
- MC_UU_12017/13/MRC_/Medical Research Council/United Kingdom
- R00 CA201542/CA/NCI NIH HHS/United States
- U01 AG009740/AG/NIA NIH HHS/United States
- D43 TW009775/TW/FIC NIH HHS/United States
- G0400491/MRC_/Medical Research Council/United Kingdom
- MC_U147585819/MRC_/Medical Research Council/United Kingdom
- MC_PC_13043/MRC_/Medical Research Council/United Kingdom
- SPHSU15/CSO_/Chief Scientist Office/United Kingdom
- SPHSU13/CSO_/Chief Scientist Office/United Kingdom
- HHSN271201300071C/AG/NIA NIH HHS/United States
- N01HC25195/HL/NHLBI NIH HHS/United States
- R01 AI124389/AI/NIAID NIH HHS/United States
- UL1 TR001881/TR/NCATS NIH HHS/United States
- P01 AG041710/AG/NIA NIH HHS/United States
- MC_U147585824/MRC_/Medical Research Council/United Kingdom
- R01 AI112339/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources